- Home
- COGT vs TCBX Comparison
COGT vs TCBX Comparison
Compare COGT & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- TCBX
- Stock Information
- Founded
- COGT 2014
- TCBX 2008
- Country
- COGT United States
- TCBX United States
- Employees
- COGT N/A
- TCBX N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- TCBX Banks
- Sector
- COGT Health Care
- TCBX Finance
- Exchange
- COGT Nasdaq
- TCBX Nasdaq
- Market Cap
- COGT 545.3M
- TCBX 454.9M
- IPO Year
- COGT 2018
- TCBX 2021
- Fundamental
- Price
- COGT $4.37
- TCBX $29.15
- Analyst Decision
- COGT Buy
- TCBX Hold
- Analyst Count
- COGT 7
- TCBX 4
- Target Price
- COGT $14.17
- TCBX $36.67
- AVG Volume (30 Days)
- COGT 1.7M
- TCBX 81.9K
- Earning Date
- COGT 05-06-2025
- TCBX 04-23-2025
- Dividend Yield
- COGT N/A
- TCBX N/A
- EPS Growth
- COGT N/A
- TCBX 40.59
- EPS
- COGT N/A
- TCBX 2.78
- Revenue
- COGT N/A
- TCBX $165,678,000.00
- Revenue This Year
- COGT N/A
- TCBX $17.61
- Revenue Next Year
- COGT N/A
- TCBX $6.52
- P/E Ratio
- COGT N/A
- TCBX $10.48
- Revenue Growth
- COGT N/A
- TCBX 17.16
- 52 Week Low
- COGT $3.72
- TCBX $18.26
- 52 Week High
- COGT $12.61
- TCBX $39.45
- Technical
- Relative Strength Index (RSI)
- COGT 34.56
- TCBX 39.80
- Support Level
- COGT $4.12
- TCBX $26.46
- Resistance Level
- COGT $5.09
- TCBX $29.32
- Average True Range (ATR)
- COGT 0.54
- TCBX 2.05
- MACD
- COGT -0.02
- TCBX -0.04
- Stochastic Oscillator
- COGT 23.90
- TCBX 46.50
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.